Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

CTI BIOPHARMA CORP (CTI)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21
   10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Net income  -93.0-112.3-120.8-117.8-97.9-76.1-63.2-57.5
Depreciation and amortization  2.01.61.20.70.50.50.50.5
Stock-based compensation  10.08.57.05.54.74.24.14.1
Change in working capital   [+]-7.91.59.013.07.95.82.20.8
Other operating activities  7.75.12.90.5-0.1-0.1-0.13.6
Cash from operations  -81.2-95.7-100.7-98.1-84.9-65.7-56.6-48.5
   
Capital expenditures  0.00.00.00.00.00.00.00.0
Purchases of intangible assets    -25.0     
Purchases of short-term investments, net  -48.9-49.4-29.8   -0.1-4.1
Cash from investing  -73.9-74.4-54.84.012.012.0-0.1-4.1
   
Option exercises  4.92.11.70.50.4 0.30.2
Financing costs   0.0-1.3-1.3    
Other cash from financing  125.0109.0150.1157.198.3103.958.74.8
Cash from financing  120.0106.9149.7157.997.9103.758.54.6
   
Free cash flow  -81.2-95.7-100.7-98.1-84.9-65.7-56.6-48.6
        Per share (diluted)  ($0.73)($0.91)($1.03)($1.04)($0.96)($0.79)($0.72)($0.66)
   
Cash paid for interest  6.16.24.73.12.00.30.40.4

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy